Genesis 4 Life Science is a call for proposals launched as part of Meet in Italy for Life Sciences (MIT4LS) 2026, an initiative organized by Cluster ALISEI and dedicated to start-ups and research teams active in the Life Sciences sector, with the goal of accelerating the development of innovative projects from research to market.
The Genesis 4 Life Science program offers acceleration tracks, targeted networking, advanced training, and access to investors and companies, supporting the growth of high-impact solutions in the following sectors: Medical Devices, Pharmaceuticals, Biotechnology, Digital Health, and Biomanufacturing.
Candidate and selected organizations will be able to participate in one of the initiative’s three paths, designed according to the project’s level of maturity:
- Tech Transfer: for research teams and academic spin-offs focused on commercializing scientific results and technology transfer.
- Growth: for start-ups ready to scale, with a focus on go-to-market strategies, fundraising, and business development.
- BRIDGE – Biomanufacturing: a vertical track dedicated to production processes, scale-up, and industrialization in biomanufacturing.
All paths include specialized workshops and mentorship sessions on:
- advanced pitching and investor relations;
- grants, calls for proposals, and funding instruments;
- technology transfer and intellectual property;
- HTA and clinical strategy;
- go-to-market and procurement;
- the Growth and BRIDGE tracks also include in-depth sector-specific modules.
The selected companies will have the opportunity to present their projects to venture capital firms, business angels, and companies in the sector during the “Meet in Italy for Life Sciences” event, scheduled for October 13 and 14, 2026, at the Auditorium della Tecnica in Rome.
Applications for the Genesis 4 Life Science program are open until Saturday, June 6, 2026. All admission requirements, selection criteria, and application procedures are available in the official call for applications on the initiative’s website.
